Join telegram
  • 🇸🇦 Saudi Stock Market
t.me/Naranj_KSA
  • 🇺🇸 USA Stock Market
t.me/Naranj_USA
العربية
العربية
العربية
العربية
العربية
العربية
العربية
العربية
العربية
العربية
العربية
Log in
Author picture

NASDAQ trade advice (D): US Health Care stock | 5-6% gain | USA stock trading signal on 23 Oct 2024

Date
Analysed By
Stock Market
NASDAQ, United States of America

Target hit. Trade closed.

GILD

Verified in  
23 Oct 2024
7 Nov 2024
7 Nov 2024
8 days
Loss per
100,000 USD
Stop-loss
84.5
Buy Advice
23 Oct 2024
86 – 88
Target 1
7 Nov 2024
92
Target 2
7 Nov 2024
93
Profit per
100,000 USD
8 days
11,751
  • 11.8%
84.5
86 – 88
92
93
11,751
  • 11.8%

Short Term Trading Advice in USA

  • Buy
  • Buy
    Range
  • Target
  • Stoploss
  • Upside
    Potential
  • Trade
    Duration
  • Gilead Sciences
  • 86 – 88
  • 92 – 93
  • Below 84.5
  • 5% – 6%
  • 12 - 14 Days
  • Buy Gilead Sciences
  • Buy
    Range     86 – 88
  • Target 92 – 93
  • Stoploss Below 84.5
  • Upside
    Potential     5% – 6%
  • Trade
    Duration     12 - 14 Days
    • * Once the first target hit, reset the StopLoss at your buying price.
    * Trade durations are approximate; actual holding period may vary.

    Gilead Sciences (NASDAQ: GILD) - Stock Overview

  • NASDAQ code
  • Stock Name
  • Sector
  • 52 Weeks High
  • 52 Weeks Low
  • GILD
  • Gilead Sciences
  • Health Care
  • 88.36
  • 62.07
  • NASDAQ code GILD
  • Stock Name Gilead Sciences
  • Sector Health Care
  • 52 Weeks High 88.36
  • 52 Weeks Low 62.07

    • Company profile

    Gilead Sciences, Inc. is a biopharmaceutical firm focused on discovering, developing, and marketing medicines for unmet medical needs globally, including the U.S. and Europe. It offers products like Biktarvy, Genvoya, and Truvada for HIV/AIDS, Veklury for COVID-19, and Epclusa for viral hepatitis. Additionally, it provides Yescarta and Tecartus for oncology, Letairis for pulmonary arterial hypertension, and AmBisome for serious fungal infections. The company collaborates with various firms, including Arcus Biosciences and Merck, and has a research agreement with Merus N.V. Founded in 1987, it is based in Foster City, California.

  • Gilead Sciences (NASDAQ: GILD) vs NASDAQ - Relative Strength Comparison

    The image highlights Gilead Sciences's performance over the last year versus NASDAQ.
    Relative Performance - Last 1 Year
    GILD —   NASDAQ —

  • Gilead Sciences (NASDAQ: GILD) - Technical Analysis (Daily)

    Gilead Sciences - Technical Analysis chart on Daily Price and Volume
    Gilead Sciences - Technical Analysis chart on Daily Price and Volume

    • After facing a significant rejection around the 90 level, the stock price fell and entered a phase of consolidation.
    • During this extended consolidation, the stock has developed a Descending Broadening pattern.
    • Following a recent breakout, the price is poised for a substantial upward movement.

  • Gilead Sciences (NASDAQ: GILD) - RSI Indicator

    Gilead Sciences stock analysis based on RSI indicator
    Gilead Sciences - RSI indicator

    • Current RSI of this stock is 70.41, which indicates the strength of buyers.

  • Gilead Sciences (NASDAQ: GILD) - ADX & DI Indicator

    Gilead Sciences stock analysis based on ADX & DI indicator
    Gilead Sciences - ADX & DI indicator

    • Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.

  • Gilead Sciences (NASDAQ: GILD) - EMA Crossover

    Gilead Sciences stock analysis based on EMA Crossover
    Gilead Sciences - EMA Crossover

    • The short length exponential moving average (10 EMA) has crossed the long length exponential moving average (20 EMA) from the below, generates bullish signal. Last day’s candle has closed above all these moving averages. This suggests buyers are taking interest in this stock.

  • Conclusion - Gilead Sciences (NASDAQ: GILD) Stock Price Forcast

    Based on our stock trading advice in United States, Gilead Sciences stock price target will be USD 92 - USD 93 in the next 12-14 trading sessions.

    • Share with
    0 0 votes
    Article Rating
    Subscribe
    Notify of
    guest
    0 Comments
    Inline Feedbacks
    View all comments

    Join Our Telegram Channel for US Stock Market Update

    t.me/Naranj_USA

    USA Stock Analysis

    Thumbnail of Prime Trading Advice - Saudi Arabia

    US Prime Trading Advice (A) | 25-Mar-2024 | Expected Gain 9%-10%

    The stock trading advice is prepared by the Naranj Capital team under the guidance of Arijit Banerjee, CMT, CFTe.
    A1 Trading Advice for USA Stock Market - Thumbnail

    NASDAQ trade advice (A): US Technology stock | 5-6% gain | USA stock trading picks on 2 Apr 2024

    Maximize your return with our precise trading advice on the USA stock exchange! We recommend an technology stock poised for
    Thumbnail of Prime Trading Advice - Saudi Arabia

    NYSE trade advice (B): US energy stock | 5-6% gain | USA stock trading idea on 2 Apr 2024

    Get expert short-term trading advice for the USA stock exchange. This energy stock is projected to deliver 5%-6% returns in
    Thumbnail of Prime Trading Advice - Saudi Arabia

    NYSE trade advice (C): US consumer discretionary stock | 5-6% gain | USA stock trading signal on 2 Apr 2024

    Short Term Trading Alert: This Consumer Discretionary stock has the upside potential of 5-6% in 14-15 trading days. Swing Trading

    Buy Qualcomm | NASDAQ – QCOM | Short Term Trading Advice | Technology Sector | 2th Apr 2024 | Expected Gain 5% – 6%

    Short Term Trading Advice: Qualcomm Inc (NASDAQ - QCOM) has the upside potential of 5-6% in 14-15 trading days

    Join Our Telegram Channel for Saudi Stock Market Update

    t.me/Naranj_KSA

    Saudi Stock Analysis

    Arabian Pipes Limited Thumbnail - Stock_Advice_for_Tadawul_stocks_by_Naranj_Capital

    Buy Arabian Pipes | Tadawul 2200 | 20-24% gain | KSA stock trading idea on 4 Nov 2023

    Maximize your return with our precise trading advice on Saudi stock exchange Tadawul! We recommend buying Arabian Pipes (Tadawul 2200)
    Thumbnail of Prime Trading Advice - Saudi Arabia

    Tadawul trade advice (A): Saudi health care equipment stock | 8-10% gain | KSA stock trading idea on 7 Nov 2023

    Short Term Trading Alert: This Saudi health care equipment stock has the upside potential of 8-10% in 12-14 trading days.
    Thumbnail - Tadawul 7040 - Etihad Atheeb Telecommunictn, تداول قو للإتصالات

    Buy Etihad Atheeb Telecom | Tadawul 7040 | 13-16% gain | Saudi stock trading signal on 7 Nov 2023

    Get expert short-term trading advice for the Saudi stock exchange Tadawul. Buy Etihad Atheeb Telecom (Tadawul 7040) for 13%-16% returns
    Thumbnail - Tadawul 4142 - Riyadh Cables Group, تداول - كابلات الرياض

    Buy Riyadh Cables Group | Tadawul 4142 | 15-17% gain | KSA stock trading picks on 16 Jan 2024

    Short term trading advice for Shariah compliant Tadawul stocks. Buy Riyadh Cables Group (Tadawul 4142) with potential for 15-17% returns
    Thumbnail of Prime Trading Advice - Saudi Arabia

    Tadawul trade advice (A): Saudi Materials stock | 7-9% gain | KSA stock trading signal on 22 Jan 2024

    Maximize your trading returns in Saudi stock exchange Tadawul! Discover a shariah halal materials sector stock having 7-9% gains in
    Details of Arijit Banerjee

    Arijit Banerjee CMT CFTe is a seasoned expert in the financial industry, boasting decades of experience in trading, investment, and wealth management. As the founder and chief strategist of Naranj Capital, he’s built a reputation for providing insightful research analysis to guide investment decisions.

    Arijit’s credentials are impressive, holding both the Chartered Market Technician (CMT) and Certified Financial Technician (CFTe) designations. These certifications demonstrate his expertise in technical analysis and financial markets.

    Through Naranj Capital, Arijit shares his market insights and research analysis, offering actionable advice for investors. His work is featured on platforms like TradingView, where he publishes detailed analysis and recommendations.

    If you’re interested in learning more about Arijit’s work or Naranj Capital’s services, you can reach out to them directly through their website